Campath Side Effects
Campath is an alemtuzumab injection for intravenous use. Campath
(alemtuzumab) is a recombinant DNA-derived humanized monoclonal antibody (Campath-IH) intended for the 21-28 kD cell surface glycoprotein, CD52. It is a colorless, sterile, isotonic solution. Campath is supplied in a 1mL single-use clear vial containing 30mg’s of alemtuzumab that should be stored at 2-8 degrees celcius
Campath is used as a single agent for the treatment of B-cell chronic lymphocytic leukemia or B-CLL. Treatment with Campath should be withheld during serious infection or other adverse reactions until resolution and should be discontinued for autoimmune anemia or thrombocytopenia.
The following side effects are associated with Campath:
· CMV viremia3
· CMV infection
Doctor directs patients to take other medications before taking Campath in order to prevent side effects, and infection in the body. Additional medications should be used exactly as prescribed.